Endothelial-dependent vasodilation is impaired in children with sickle cell disease

Haematologica

Volumn 92, Issue 12, 2007, Pages 1709-1710

  De Montalembert, Mariane ^a   Aggoun, Yacine ^a   Niakate, Assa ^a   Szezepanski, Isabelle ^a   Bonnet, Damien ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; HEMOGLOBIN; LACTATE DEHYDROGENASE; NITRIC OXIDE;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART OUTPUT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPEREMIA; MALE; RIGIDITY; SCHOOL CHILD; SICKLE CELL ANEMIA; VASODILATATION;

ADOLESCENT; ANEMIA, SICKLE CELL; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; CHILD; FEMALE; HUMANS; MALE; NITROGLYCERIN; TUNICA INTIMA; VASODILATION; VASODILATOR AGENTS;

EID: 37049023457     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11253     Document Type: Article

References (12)

1. Reiter CD, Gladwin MT. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr Opin Hematol 2003; 10:99-107.
2. Kaul DK, Liu XD, Fabry ME, Nagel RL. Impaired nitric-oxide mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol 2000;278:H799-H1806.
3. Nath KA, Shah V, Haggard JJ, Croatt AJ, Smith LA, Hebbel RP, et al. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol 2000;279: R1949-R1955.
4. Eberhardt E, McMahon L, Duffy SJ, Steinberg MH, Perrine SP, Loscalzo J, et al. Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. Am J Hematol 2003;74:104-11.
5. Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C, et al. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 2001;97:1584-9.
6. Aessopos A, Farmakis D, Tsironi M, Diamanti-Kandarakis E, Matzourani M, Fragodimiri C, et al. Endothelial function and arterial stiffness in sickle-thalassemia patients. Atherosclerosis 2007;427-32.
7. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001;358:1400-4.
8. Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death are associated with relative hypertension in sickle cell anemia. Am J Med 1997;102:171-7.
9. Varat MA, Adolph RJ, Fowler NO. Cardiovascular effects of anemia. Am Heart J 1972;83:415-26.
10. Kato GJ, McGowan V, Machado RF, Little JA, Taylor 6th J, Morris CR, et al. Lactate deshydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006;107:2279-85.
11. Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006;5:501-12.
12. Morris CR, Kuypers FA, Larkin S, Sweeters N, Simon J, Vichinsky EP, et al. Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. Br J Haematol 2000;111:498-500.